Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Amneal Pharmaceuticals, Inc.

http://www.amneal.com

Latest From Amneal Pharmaceuticals, Inc.

Amneal Completes Hat Trick With Delayed $2.6bn US Pegfilgrastim Entry

With its pure partnered approach, US-based player Amneal has tallied up its third biosimilar launch in the market.

Biosimilars Launches

Amneal Eyes Multiple Targets As It Seeks To Maintain Momentum

As Amneal reported first-quarter results, the firm’s management pointed to a number of specific product opportunities on the horizon as the company seeks to maintain growth momentum.

Sales & Earnings Strategy

Celltrion CCO On The Big US Build-Up, Direct Sales Model

Celltrion USA’s chief commercial officer Thomas Nusbickel tells Scrip how he’s shaping the South Korean group’s operations ahead of key launches that include assets in the immunology segment. He also weighs in on whether big pharma will stay in the biosimilars game over the long term.

Commercial Biosimilars

Proud Amneal Offers Preview Of Q1 Growth

Ahead of revealing its full first-quarter results, Amneal has released limited preliminary details of its financials for the first three months of 2023, pointing to double-digit sales and profit growth in Q1.

Sales & Earnings Generic Drugs
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
    • Specialty Pharmaceuticals
  • Other Names / Subsidiaries
    • Amedra Pharmaceuticals LLC
    • Amneal Pharmaceuticals, LLC
    • CorePharma LLC
    • Gemini Laboratories, LLC
    • Impax Generics
    • Impax Laboratories, Inc. (IPXL)
    • Impax Specialty Pharma
    • Lineage Therapeutics Inc.
    • Tower Holdings, Inc.
UsernamePublicRestriction

Register